CyteGuard AB is currently seeking partners for continued development of the project, to become the new, state-of-the-art storage and quality control system for platelet concentrates. A pre-study with American Red Cross Holland Labs research blood bank in Washington D.C. is in the planning stages.
Market
Dynamics:
Growth in the market
for CyteGuard is attributed to increasing investments in the biomedical
sciences sector, increased prevalence of disorders
related to platelets, and increased QC demands
Market Size:
Current estimates for the global platelet
agitator market predict a growth of 4.10% to a total of USD 502.5 million by
2027 Source
: MRFR
Analysis Based on end user, the global market has been segmented into
autonomous blood banks, hospital-based blood banks.
We
believe there is demand for two storage systems with
different storage capacity, e.g.:
· CyteGuard
Large, with a capacity of >32 bags, aimed at transfusion centers.
· CyteGuard Small, with a capacity of e.g. <8
bags, for clinics and smaller hospitals.
The
market potential for CyteGuard Large is equals the current market size of platelet agitators.
The market potential for CyteGuard Small is
extremely large since the device can be placed on every hospital ward or
department where platelet transfusions are performed. This means several
devices per hospital.
created with
Website Builder Software .